Legal & General Group’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.5K | Hold |
|
|||||
|
2025
Q1 | $9.38K | Hold |
|
|||||
|
2024
Q4 | $16K | Hold |
|
|||||
|
2024
Q3 | $12.1K | Buy |
|
|||||
|
2024
Q2 | $15.8K | Sell |
|
|||||
|
2024
Q1 | $24.2K | Sell |
|
|||||
|
2023
Q4 | $279K | Hold |
|
|||||
|
2023
Q3 | $313K | Sell |
|
|||||
|
2023
Q2 | $826K | Buy |
|
|||||
|
2023
Q1 | $1.07M | Sell |
|
|||||
|
2022
Q4 | $1.25M | Buy |
|
|||||
|
2022
Q3 | $1.49M | Buy |
|
|||||
|
2022
Q2 | $1.1M | Sell |
|
|||||
|
2022
Q1 | $1.98M | Sell |
|
|||||
|
2021
Q4 | $2.47M | Buy |
|
|||||
|
2021
Q3 | $2.41M | Buy |
|
|||||
|
2021
Q2 | $1.98M | Sell |
|
|||||
|
2021
Q1 | $2.66M | Buy |
|
|||||
|
2020
Q4 | $3.06M | Buy |
|
|||||
|
2020
Q3 | $3.22M | Buy |
|
|||||
|
2020
Q2 | $3.04M | Buy |
|
|||||
|
2020
Q1 | $231K | Sell |
|
|||||
|
2019
Q4 | $271K | Buy |
|
|||||
|
2019
Q3 | $284K | Buy |
|
|||||
|
2019
Q2 | $257K | Buy |
|
|||||
|
2019
Q1 | $131K | Buy |
|
|||||
|
2018
Q4 | $82K | Buy |
|
|||||
|
2018
Q3 | $133K | Buy |
|
|||||
|
2018
Q2 | $102K | Buy |
|
|||||
|
2018
Q1 | $78K | Sell |
|
|||||
|
2017
Q4 | $92K | Hold |
|
|||||
|
2017
Q3 | $139K | Buy |
|
|||||
|
2017
Q2 | $134K | Buy |
|
|||||
|
2017
Q1 | $173K | Buy |
|
|||||
|
2016
Q4 | $202K | Buy |
|
|||||
|
2016
Q3 | $110K | Hold |
|
|||||
|
2016
Q2 | $66K | Hold |
|
|||||
|
2016
Q1 | $82K | Sell |
|
|||||
|
2015
Q4 | $101K | Hold |
|
|||||
|
2015
Q3 | $91K | Hold |
|
|||||
|
2015
Q2 | $123K | Buy |
|